TWD
True Wealth Design Portfolio holdings
AUM
$284M
1-Year Return
11.73%
This Quarter Return
+0.13%
1 Year Return
+11.73%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$263M
AUM Growth
+$4.82M
(+1.9%)
Cap. Flow
+$5.62M
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
84.55%
Holding
2,695
New
1,342
Increased
808
Reduced
381
Closed
45
Top Buys
| 1 |
Alpha Architect 1-3 Month Box ETF
BOXX
|
+$918K |
| 2 |
Avantis US Equity ETF
AVUS
|
+$336K |
| 3 |
ConocoPhillips
COP
|
+$298K |
| 4 |
Worthington Enterprises
WOR
|
+$298K |
| 5 |
Worthington Steel
WS
|
+$160K |
Top Sells
Sector Composition
| 1 | Technology | 2.53% |
| 2 | Industrials | 1.66% |
| 3 | Healthcare | 1.31% |
| 4 | Financials | 1.3% |
| 5 | Consumer Discretionary | 1.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Ethan Allen Interiors
ETD
$747M
| $5.62K | ﹤0.01% |
203
-84
| -29% | -$2.33K |
|
652
Ultra Clean Holdings
UCTT
$1.11B
| $5.57K | ﹤0.01% |
260
+251
| +2,789% | +$5.37K |
|
653
Pultegroup
PHM
$27B
| $5.55K | ﹤0.01% |
54
+38
| +238% | +$3.91K |
|
654
Fair Isaac
FICO
$37.1B
| $5.53K | ﹤0.01% |
3
-18
| -86% | -$33.2K |
|
655
Organogenesis Holdings
ORGO
$620M
| $5.48K | ﹤0.01% |
1,268
+4
| +0.3% | +$17 |
|
656
TE Connectivity
TEL
$61.7B
| $5.44K | ﹤0.01% |
38
+20
| +111% | +$2.86K |
|
657
Zimmer Biomet
ZBH
$20.6B
| $5.43K | ﹤0.01% |
48
-218
| -82% | -$24.7K |
|
658
FedEx
FDX
$53.3B
| $5.4K | ﹤0.01% |
22
+5
| +29% | +$1.23K |
|
659
Darden Restaurants
DRI
$24.7B
| $5.4K | ﹤0.01% |
26
+17
| +189% | +$3.53K |
|
660
MetLife
MET
$52.7B
| $5.4K | ﹤0.01% |
67
+57
| +570% | +$4.6K |
|
661
Keysight
KEYS
$29.1B
| $5.39K | ﹤0.01% |
36
+28
| +350% | +$4.19K |
|
662
Workiva
WK
$4.32B
| $5.39K | ﹤0.01% |
71
+59
| +492% | +$4.48K |
|
663
XP
XP
$9.59B
| $5.39K | ﹤0.01% |
+392
| New | +$5.39K |
|
664
Best Buy
BBY
$16.2B
| $5.37K | ﹤0.01% |
73
-476
| -87% | -$35K |
|
665
Dillards
DDS
$8.87B
| $5.37K | ﹤0.01% |
15
-41
| -73% | -$14.7K |
|
666
Matrix Service
MTRX
$393M
| $5.37K | ﹤0.01% |
432
+124
| +40% | +$1.54K |
|
667
Myriad Genetics
MYGN
$649M
| $5.31K | ﹤0.01% |
598
+480
| +407% | +$4.26K |
|
|
GTM
668
ZoomInfo Technologies
GTM
$3.36B
| $5.3K | ﹤0.01% |
+530
| New | +$5.3K |
|
669
Myers Industries
MYE
$605M
| $5.29K | ﹤0.01% |
443
+425
| +2,361% | +$5.07K |
|
670
Axon Enterprise
AXON
$57.5B
| $5.26K | ﹤0.01% |
10
+7
| +233% | +$3.68K |
|
671
Quest Diagnostics
DGX
$20.4B
| $5.25K | ﹤0.01% |
31
-76
| -71% | -$12.9K |
|
672
Yum China
YUMC
$16.2B
| $5.21K | ﹤0.01% |
100
| – | – |
|
673
ACM Research
ACMR
$1.79B
| $5.21K | ﹤0.01% |
223
+176
| +374% | +$4.11K |
|
674
Westlake Corp
WLK
$11B
| $5.2K | ﹤0.01% |
52
+48
| +1,200% | +$4.8K |
|
675
Apellis Pharmaceuticals
APLS
$3.39B
| $5.18K | ﹤0.01% |
237
-930
| -80% | -$20.3K |
|